Related Experiment Video
Updated: May 29, 2026
09:29
Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
Published on: March 5, 2019
Current therapeutic options for hyponatremia: indications, limitations, and confounding variables
1Department of Neuroscience, Barnes-Jewish Hospital, St. Louis, Missouri 63110, USA. txm5120@bjc.org
Pharmacotherapy
|September 20, 2011
Summary
Arginine vasopressin receptor antagonists (vaptans) offer a targeted approach for hyponatremia, improving serum sodium levels and clinical outcomes. This new drug class addresses limitations of traditional therapies for patients with specific types of hyponatremia.
Area of Science:
- Endocrinology
- Nephrology
- Pharmacology
Background:
- Hyponatremia management presents challenges due to variable efficacy and safety concerns with traditional therapies like diuretics and fluid restriction.
- Existing treatments lack specificity for the underlying pathophysiology of abnormal arginine vasopressin release.
- Arginine vasopressin receptor antagonists (vaptans) represent a novel therapeutic class targeting this specific mechanism.
Purpose of the Study:
- To evaluate the efficacy and safety of arginine vasopressin receptor antagonists (vaptans) in treating hyponatremia.
- To compare the effectiveness of vaptans against traditional hyponatremia therapies.
- To assess the role of vaptans in addressing unmet medical needs in hyponatremia patients.
Main Methods:
- Review of clinical data and studies on arginine vasopressin receptor antagonists.
- Analysis of patient outcomes, including serum sodium concentration and clinical status.
- Comparison of vaptan therapy with conventional treatments for hyponatremia.
Main Results:
- Vaptans demonstrate a favorable effect on serum sodium concentration in patients with hypervolemic and euvolemic hyponatremia.
- This new class of drugs targets the core pathophysiology of abnormal arginine vasopressin release.
- Clinical outcomes in patients treated with vaptans show improvement.
Conclusions:
- Arginine vasopressin receptor antagonists (vaptans) provide a targeted and effective treatment option for hyponatremia.
- Further clinical experience is required to establish precise treatment criteria for vaptan use.
- Vaptans represent a significant advancement in managing hypervolemic and euvolemic hyponatremia.
Related Concept Videos
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:26Regulation of Sodium and Potassium
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:22Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...